March 11, 2007 C-Path Adopts Rosetta Resolver® System for the PSTC Rosetta Biosoftware announced today that The Critical Path Institute (C-Path) adopted the Rosetta Resolver® system for C-PathR
March 10, 2007 Raymond Woosley, M.D., Ph.D., Provides Expert Testimony in Congressional Hearings President and CEO of The Critical Path Institute (C-Path) provided testimony and answered questions about drug development yesterd
November 11, 2006 Tucson Nonprofit Seeks to Get Cures to Patients Faster A little-noticed 2004 report from the Food and Drug Administration contained a bombshell. Although spending on research and develo
November 11, 2006 New Corporate Members and Leaders for C-Path’s Predictive Safety Testing Consortium Announced The Critical Path Institute (C-Path) today announced seven new members that have recently joined the Predictive Safety Testing Con
September 11, 2006 C-Path Receives $675,000.00 Award for FDA Collaboration The Critical Path Institute (C-Path) has received $675,000 from the US Food and Drug Administration (FDA) for the first year of wh
April 11, 2006 Valley Fever Cure a Step Closer The federal government is backing the first potential cure for valley fever, a serious lung disease that has spiked in recent year
April 10, 2006 C-Path Announces the Appointment of Jeffery Cossman, M.D., as Chief Scientific Officer The Critical Path Institute (C-Path), today announced the appointment of Jeffrey Cossman, M.D., an internationally recognized expe
March 11, 2006 FDA Release: The Predictive Safety Testing Consortium The Food and Drug Administration (FDA) and The Critical Path Institute (C-Path) today announced the formation of the Predictive Sa
March 11, 2006 C-Path Forms Drug Testing Pact The Tucson-based Critical Path Institute on Thursday announced an unprecedented agreement with eight major pharmaceutical companie
February 11, 2006 Drug Research Institute Sdds Liason From UA The retired head of research at the University of Arizona has joined the Tucson-based Critical Path Institute, a UA- and FDA-affil